| VIVANI MEDICAL |
| USA |
| Gesundheit |
| US92854B1098 / A3DTRX |
| U5P (Frankfurt) / VANI (NASDAQ) |
| FRA:U5P, ETR:U5P, U5P:GR, NASDAQ:VANI |
| - |
| https://vivani.com/ |
|
Vivani Medical Inc. is a clinical-stage biopharmaceutical company focused on developing miniature, ultra long-acting subdermal drug implants using its proprietary NanoPortal technology. The company’s current work centers on implant-based therapies ..
>Volltext.. |
| 82.66 Mio. EUR |
| 85.15 Mio. EUR |
| - |
| -24.98 Mio. EUR |
| -24.53 Mio. EUR |
| -0.3 EUR |
| 15.8 Mio. EUR |
| 13.24 Mio. EUR |
| -22.99 Mio. EUR |
| 2.22 |
| - |
| -7.59% |
| - |
| - |
| - |
| VIVANI MEDICAL, VIVANI MED |
| 16.11.26 |
|